ULBI - Ultralife Corporation

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5128.27M
Enterprise Value 3105.76M
Trailing P/E 5.70
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.55
Price/Book (mrq)1.23
Enterprise Value/Revenue 31.27
Enterprise Value/EBITDA 614.96

Trading Information

Stock Price History

Beta (3Y Monthly) 1.43
52-Week Change 3-20.99%
S&P500 52-Week Change 37.06%
52 Week High 311.97
52 Week Low 36.30
50-Day Moving Average 38.01
200-Day Moving Average 38.95

Share Statistics

Avg Vol (3 month) 346.52k
Avg Vol (10 day) 314.73k
Shares Outstanding 515.74M
Float 9.8M
% Held by Insiders 13.86%
% Held by Institutions 179.53%
Shares Short (Jun 28, 2019) 4102.32k
Short Ratio (Jun 28, 2019) 42.3
Short % of Float (Jun 28, 2019) 41.04%
Short % of Shares Outstanding (Jun 28, 2019) 40.65%
Shares Short (prior month May 31, 2019) 475.06k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 27.96%
Operating Margin (ttm)5.72%

Management Effectiveness

Return on Assets (ttm)2.70%
Return on Equity (ttm)24.90%

Income Statement

Revenue (ttm)83M
Revenue Per Share (ttm)5.22
Quarterly Revenue Growth (yoy)-18.10%
Gross Profit (ttm)25.58M
EBITDA 7.07M
Net Income Avi to Common (ttm)23.2M
Diluted EPS (ttm)1.43
Quarterly Earnings Growth (yoy)-80.20%

Balance Sheet

Total Cash (mrq)21.24M
Total Cash Per Share (mrq)1.35
Total Debt (mrq)848k
Total Debt/Equity (mrq)0.82
Current Ratio (mrq)4.09
Book Value Per Share (mrq)6.61

Cash Flow Statement

Operating Cash Flow (ttm)11.26M
Levered Free Cash Flow (ttm)4.42M